<DOC>
	<DOCNO>NCT01753232</DOCNO>
	<brief_summary>Low Density Lipoprotein ( LDL ) -apheresis refers procedure blood take patient 's vein clean pathogenic substance , e.g . cholesterol , outside body give back patient . In DALI ( Direct Adsorption Lipoproteins ) -system whole blood pump adsorber contain bead selectively bind LDL-cholesterol . The MONET ( Membrane filtration Optimized Novel Extracorporeal Treatment ) -system work plasma clean filtration . This study comprise record safety efficacy data patient treat either DALI MONET-system period 2 year .</brief_summary>
	<brief_title>Safety Efficacy DALI LDL-adsorber MONET Lipoprotein Filter</brief_title>
	<detailed_description>Data record patient suffer familial hypercholesterolemia treat lipid apheresis use one two system investigate least 3 month prior inclusion study . Only treatment document routine blood sample laboratory analysis take , adverse serious adverse device effect occur .</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Hyperlipoproteinemias</mesh_term>
	<mesh_term>Hyperlipoproteinemia Type II</mesh_term>
	<criteria>give informed consent 18 year old patient compliant therapy prescribe least two therapy session per month treatment DALI MONET system least 3 month inclusion last severe invasive intervention hospital 3 month ago early participation study unconscious patient/persons without capacity contract DALI : intake ACEinhibitors</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>DALI adsorber</keyword>
	<keyword>MONET lipoprotein filter</keyword>
</DOC>